FindTrial
Sign In

Study of microbiome in liver cancer and liver cirrhosis

Study of microbiome in liver cancer and liver cirrhosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014756
Enrollment
Unknown
Registered
2018-02-02
Start date
2018-02-12
Completion date
Unknown
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver diseases

Interventions

Case series:Nil

Sponsors

The First Hospital of Jiaxing (The First Hospital affliated to Jiaxing College)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Liver diseases such as liver cancer, cirrhosis and liver fibrosis were not used within the past 3 months. Male and female aged 18 to 80 years old.

Exclusion criteria

Exclusion criteria: Serious diseases such as heart, lung and liver diseases.

Design outcomes

Primary

MeasureTime frame
microbiome metagenomic;—

Countries

China

Contacts

Public ContactLinghua Yu

Jiaxing First Hospital (The First Hospital affliated to Jiaxing College)

ylhyqh@hotmail.com+86 15825705735

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026